Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.37 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7438949 | 0.80 | KMT2A (0.42) | KMT2AMAPK1L3MBTL1MEN1TDP1 | |
| SCHEMBL7464263 | 0.78 | MBOAT4 (0.37) | TSHR | |
| SCHEMBL11067308 | 0.72 | KMT2A (0.54) | KMT2AMAPK1L3MBTL1MEN1TDP1 | |
| SCHEMBL13836388 | 0.72 | KMT2A (0.48) | KMT2AMAPK1L3MBTL1MEN1TDP1 | |
| SCHEMBL61427 | 0.70 | MAPT (0.48) | KMT2AMAPK1L3MBTL1MEN1TDP1 | |
| SCHEMBL1126888 | 0.69 | MAPT (0.48) | KMT2AMEN1ALDH1A1POLBTSHR | |
| SCHEMBL28053897 | 0.69 | GRM2 (0.37) | ALDH1A1POLBTSHRGAAKDM4E | |
| SCHEMBL29722397 | 0.69 | MAPT (0.48) | KMT2AMEN1ALDH1A1POLBTSHR | |
| SCHEMBL1998596 | 0.69 | ALDH1A1 (0.50) | KMT2AALDH1A1TSHRGAAKDM4E | |
| SCHEMBL3893783 | 0.68 | KMT2A (0.46) | KMT2AMAPK1L3MBTL1MEN1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8343382-B2 | Band gap control in conjugated oligomers and polymers via Lewis acids | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-01-01 | — | — | US | disclosed |
| US-20110028656-A1 | Band gap control in conjugated oligomers and polymers via Lewis acids | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2011-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028656-A1 | Band gap control in conjugated oligomers and polymers via Lewis acids | PCNA, CLTB, GJB2 | KMT2A 2226/4885MAPK1 2811/4885L3MBTL1 1250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.